Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live sha256:5fb43
    4/30/2026, 2:41:24 PM
    Content snapshot 
    {
  "nct_id": "NCT04437511",
  "phase": "phase_3",
  "status": "completed",
  "domain": "alzheimers",
  "indication": "Early Symptomatic Alzheimer's Disease",
  "intervention": "Donanemab (anti-N3pG amyloid)",
  "sponsor": "Eli Lilly",
  "n_enrolled": 1736,
  "primary_endpoint": "Integrated AD Rating Scale (iADRS) at 76 weeks",
  "summary": "35% slowing on iADRS in low/medium tau population; 2nd FDA-approved disease-modifier (Kisunla, July 2024).",
  "metadata": {}
}